AXIGEN Releases New Version With Real Time Antispam Protection

Bucharest, Romania (PressExposure) October 09, 2008 -- AXIGEN (http://www.axigen.com), the professional messaging solution vendor, announces today the commercial release of version 6.2 of the AXIGEN Mail Server featuring Commtouchâs real time antispam protection and many other important security and delegated administration functionalities.

âAiming to maintain our development focus on Service Providers, this new version of the AXIGEN Mail Server is designed to support SPs in their efforts to provide complex and efficient services to business customers. The new security features, the real time performance reports and the increased control over the smallest details of email communication will help them build a high-end range of Software as a Service (Saas) offerings for the corporate client segment,â said Oana Bornaz, AXIGEN CEO.

Winner of the ServerWatch 2007 Product Excellence Award for the Communications Server category, the AXIGEN Mail Server also runs on several Linux and BSD distributions, on Solaris, on Windows operating systems, on PowerPC and SPARC architectures and is becoming the messaging solution of choice for a growing number of service providers and enterprises worldwide.

About Gecad Technologies

Established in 2001, Gecad Technologies SA, member of the GECAD Group, is the vendor of AXIGEN, a messaging solution for professionals that ensures an efficient and secure worldwide communication environment and business growth for both service providers and companies of all sizes. Currently, AXIGEN is distributed internationally by over 160 partners from 80 countries and manages email traffic for more than 10,000 companies with 6 million end-users.

Our team of seasoned professionals, with 15 years of experience in messaging and IT security delivers cutting-edge products, by developing an innovative carrier-class technology based on proprietary architectures such as AXIGEN GrowSecureTM, AXIGEN SmartProcessingTM and AXIGEN UltraStorageTM. For further details, please visit: http://www.axigen.com